Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00397826
Status:
COMPLETED
Last Update Posted:
2016-01-07
First Post:
2006-11-09
Brief Title:
Evaluation of the Effects of Simvastatin 40mg
Sponsor:
Cardinal Tien Hospital
Organization:
Cardinal Tien Hospital
Study Overview
Official Title:
Evaluation of the Effects of Simvastatin 40 Mg on Lipid Profiles and Specified Circulatory Parameters in Normotensive Hypercholesterolemia PatientsMK-0733-265
Status:
COMPLETED
Status Verified Date:
2016-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To collect lipid-lowering response data with the use of simvastatin 40 mg tablet in patients with hypercholesterolemia
Detailed Description:
This is an open-label prospective study to investigate lipid-lowering efficacy and sympathetic response of normotensive hypercholesterolemia patients after receiving simvastatin 40 mg once daily for 3 months
The total duration of the study will be approximately 13 weeks comprising of a 1-week or 4 weeks screening period and a 12-week active treatment period 20 hypercholesterolemia patients with normal blood pressure will be enrolled into treatment group
The total duration of the study will be approximately 13 weeks comprising of a 1-week or 4 weeks screening period and a 12-week active treatment period 20 hypercholesterolemia patients with normal blood pressure will be enrolled into treatment group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None